z-logo
open-access-imgOpen Access
Dupilumab treatment of a case of asthma, chronic rhinosinusitis, and atopic dermatitis after initial benralizumab administration
Author(s) -
MatsudaHirose Haruna,
Takeo Naoko,
Ando Masaru,
Kizu Yumi,
Hatano Yutaka
Publication year - 2020
Publication title -
journal of cutaneous immunology and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.127
H-Index - 1
ISSN - 2574-4593
DOI - 10.1002/cia2.12115
Subject(s) - dupilumab , benralizumab , atopic dermatitis , medicine , asthma , chronic rhinosinusitis , dermatology , immunology , eosinophil , mepolizumab
The present paper reports a patient with asthma, chronic rhinosinusitis, and atopic dermatitis treated by dupilumab after initial benralizumab administration. Benralizumab was moderately effective on asthma but not for chronic rhinosinusitis and atopic dermatitis. Dupilumab was strongly effective on both asthma and atopic dermatitis but not on chronic rhinosinusitis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here